Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of favipiravir 200 mg vs Avigan 200 mg in healthy Thai volunteers (fasting)
TCTR20210823005Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of favipiravir (2 arms), sponsored by Bio-innova. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
favipiravir
Beyond the preview
Go deeper on TCTR20210823005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210823005.